| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $1.0M | +30.7% |
| SG&A Expense | $3.8M | +7.5% |
| Operating Income | -$7.9M | -5.9% |
| Pre-tax Income | -$8.7M | +1.0% |
| Income Tax | $0 | — |
| Net Income | -$8.7M | +1.0% |
| EPS (Basic) | -$3.39 | +73.8% |
| EPS (Diluted) | -$3.39 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.7M | +236.4% |
| Accounts Receivable | $353 | -28.5% |
| Current Assets | $2.8M | +231.2% |
| Total Assets | $5.3M | +20.3% |
| Current Liabilities | $551K | -86.2% |
| Total Liabilities | $604K | -84.8% |
| Stockholders' Equity | $4.7M | +1016.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.1M | -13.1% |
| Capital Expenditures | $12K | +406.4% |
| Investing Cash Flow | -$1.0M | +2.6% |
| Financing Cash Flow | $8.0M | +71.0% |
| Free Cash Flow | -$5.1M | -13.3% |
| +73.8% |